COVID-19 and the Development of Type 1 Diabetes
During the pandemic, the incidence of type 1 diabetes (T1D) increased, but the jump could not be attributed to COVID-19 in a 2015–2021 study of
During the pandemic, the incidence of type 1 diabetes (T1D) increased, but the jump could not be attributed to COVID-19 in a 2015–2021 study of
Antibiotic use could be reduced by testing for specific bacteria when children present with acute sinusitis, a study shows. For those without nasopharyngeal bacterial pathogens
A position paper from the American College of Physicians (ACP) offers “several policy recommendations for enhancing federal, state, and local preparedness for future pandemic and
A hexavalent anti–capsular polysaccharide (CPS)–cross-reactive material 197 glycoconjugate vaccine (GBS6) was immunogenic and resulted in the transfer of protective antibodies to young infants at levels
An analysis of previously reported data beyond week 48 reinforces the clinical utility of baseline factors in the appropriate use of cabotegravir + rilpivirine long-acting (CAB + RPV LA).
Compared with intermittent dosing in critically ill patients, “continuous administration of meropenem did not improve the composite outcome of mortality and emergence of pandrug-resistant or
Reducing unnecessary urine cultures through diagnostic stewardship is an effective way of reducing antibiotic treatment of patients with asymptomatic bacteriuria (ASB), according to findings of
In a study of postpartum hemorrhage conducted in Africa, early detection of postpartum hemorrhage and use of bundled treatment led to a lower risk of
After 48 weeks of this phase 3 trial, bulevirtide treatment reduced hepatitis D virus (HDV) RNA and ALT levels in patients with HDV and hepatitis
Results of a case–control study of electronic health record (EHR) data show that U.S. patients with mpox (formerly monkeypox) were less likely to have received